Showing results (121-130 of 153) with videos related to

Sort By:
Pageof 16
International Journal of Molecular Sciences|October 14, 2022
Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B VirusYaojia Ma, Shingo Nakamoto, Junjie Ao, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 11, 2022
Carbon-ion radiotherapy versus radiofrequency ablation as initial treatment for early-stage hepatocellular carcinomaNaoto Fujita, Naoya Kanogawa, Hirokazu Makishima, et al.
International Cancer Conference Journal|April 3, 2026
Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinomaHaruka Anzai, Chihiro Miwa, Sadahisa Ogasawara, et al.
Liver Cancer|March 27, 2025
Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic TherapyMasanori Inoue, Sadahisa Ogasawara, Kazufumi Kobayashi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 2022
A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosisTakafumi Sakuma, Masato Nakamura, Tetsuhiro Chiba, et al.
JHEP Reports : Innovation in Hepatology|March 29, 2026
MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trialSadahisa Ogasawara, Keisuke Koroki, Hirokazu Makishima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 29, 2024
Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage-associated molecular pattern analysisTomomi Ozaki, Sae Yumita, Sadahisa Ogasawara, et al.
International Immunopharmacology|March 31, 2023
Alteration of the tumor microenvironment by pharmacological inhibition of EZH2 in hepatocellular carcinomaNa Qiang, Junjie Ao, Masato Nakamura, et al.
Journal of Cancer|April 15, 2021
Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinomaJunjie Ao, Tetsuhiro Chiba, Hiroaki Kanzaki, et al.
Drugs - Real World Outcomes|July 19, 2023
Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective AnalysisHiroaki Kanzaki, Sadahisa Ogasawara, Tomomi Okubo, et al.
Pageof 16